Valeant Pharma (NYSE: VRX) declined 38% to session lows at ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Trader Talk

Valeant meltdown costs investors billions; Ackman ups stakeOctober 21, 2015 1:01 PM Valeant (VRX) Philidor Concern Likely Misinformation - NomuraOctober 21, 2015 12:29 PM Hedge Funds on Edge as Valeant Pharma (VRX) SinksOctober 21, 2015 11:13 AM Valeant Pharma (VRX) Halted on Circuit BreakerOctober 21, 2015 10:24 AM Citron Research says it has a 'smoking gun' on Valeant Pharma (VRX)October 21, 2015 10:10 AM